Skip to main content
. 2021 Sep 28;2(12):1998–2009. doi: 10.34067/KID.0005062021

Figure 2.

Figure 2.

AlloMap Kidney differentiates quiescence from rejection in a single-center validation set. (A) Biopsy specimen–defined rejection (n=11) is significantly different from biopsy specimen–defined no rejection (n=8). (B) All three rejection groups are elevated relative to NR (NR, n=8; TCMR, n=7; ABMR, n=2; mixed rejection, n=2). (C) Receiver operating characteristic plot for the second validation set NR versus rejection (TCMR, ABMR, and mixed rejection). Unpaired t test.